595 
Leg Fat Is Decreased but Arm Fat Is Increased in HIV-infected Children and Adolescents Receiving Antiretroviral Medications
Stephen Arpadi*1, J Bethel2, M Horlick1, M Sarr2, M Bamji3, E Abrams4, M Puswani5, and E Engelson1
1St Luke`s Roosevelt Hosp Ctr, Columbia Univ, New York, NY, US; 2Westat, Bethesda, MD, US; 3Metropolitan Hosp Ctr, New York, NY, US; 4Harlem Hosp Ctr, New York, NY, US; and 5Bronx-Lebanon Hosp Ctr, NY, US
Background: Lipodystrophy is reported in pediatric
HIV infection. However, few studies use objective measures or include healthy
subjects for comparison. The study aim was to longitudinally compare regional
fat distribution in perinatally HIV+ youth receiving ART to healthy
controls (HIV–).
Methods: Baseline and 2 annual follow-up dual energy
x-ray absorptiometry (DEXA) scans were performed in HIV+ and HIV–
subjects. Total, leg, arm, and trunk fat masses and fat distribution as the
percentage of total body fat in each region were compared. Anthropometrics and
pubertal stage were also obtained.
Results: We enrolled 64 HIV+ and 147 HIV–
subjects ages 6 to 16 years. HIV+ and HIV– subjects were
similar at baseline with respect to pubertal stage, sex, height-for-age, and
weight-for-age. However, the HIV+ group was younger, 10.3 (3.7) vs
11.6 (2.8) years (mean [SD]; p = 0.002), and had a greater proportion of
African Americans, 69 vs 48%, (p = 0.006). All HIV+ subjects
were infected perinatally and receiving ≥3-drug ART. HIV+ and
HIV– did not differ in total fat mass or trunk fat as percentage of
total, but the HIV+ group had significantly lower leg and greater
arm fat as percentage of total at baseline, and 1 and 2 years compared to the
HIV– group. Annual gain in total, leg, and trunk fat mass did not
differ between groups, but HIV+ gained more arm fat. Differences in
arm and leg fat as percentage of total remained significant and greater trunk
fat as percentage of total in HIV+ was revealed when age, sex, race,
height, and pubertal stage were accounted for by mixed effect modeling.
Differences in arm fat as percentage of total fat increased with age (see the
figure). Among HIV+ subjects, no differences in fat distribution
were observed by treatment category (zidovudine [AZT] or stavudine [d4T] vs no
AZT or d4T, protease inhibitor [PI] vs no PI, NNRTI vs no NNRTI).
Conclusions: Serial objective measurements performed
over 2 years confirm that despite having similar body fat content, perinatally
HIV-infected youth have differences in the pattern of regional fat distribution
than healthy subjects. This includes increased trunk and decrease leg fat, as
previously reported. However, in contrast to prior reports, arm fat is
significantly increased. This pattern appears to persist through sexual
maturation. The metabolic implications of these findings remain to be explored.

|